A new anti-infl ammatory therapy for COPD

3^rd International Conference on Chronic Obstructive Pulmonary Disease

July 11-12, 2016 Brisbane, Australia

Qian Zeng

Medi7 Bentleigh, Australia

Scientific Tracks Abstracts: J Pulm Respir Med

Abstract :

COPD is a chronic progressive infl ammatory lung disease. It is caused by various stimuli, like smoking, air pollution; all these stimuli can cause small airway and lung tissue injury, which induces an infl ammatory reaction. Th e ongoing infl ammation in small airway and lung tissue will continue to cause tissue damage as a result, the lung function in COPD patients will progressively deteriorate. Th e key in treating COPD is to treat the infl ammation. Current treatments of COPD are LAMA, LABA and ICS. LAMA and LABA only treat the symptoms of COPD by dilating the small airway; they do not target the underlying mechanism of COPD (the infl ammation). ICS can only temporarily suppress the infl ammation in COPD, cannot really terminate the infl ammatory reaction and therefore it cannot stop the progression of COPD. Steroid resistance is a big issue in treating COPD and other chronic infl ammatory lung diseases, like asthma, pulmonary fi brosis. In order to eff ectively treat COPD, we must fi nd new anti-infl ammatory therapies or developing new anti-infl ammatory drugs. I have found that the smoke or tar of burning Artemisia argyi; an herb, also called moxa had special anti-infl ammatory eff ect, which is diff erent to steroid. It not only can eff ectively treat steroid resistant chronic infl ammation, but also can terminate chronic self-perpetuating infl ammation. I have treated twenty fi ve COPD patients with inhalation of the smoke of burning Artemisia argyi. 3 patients did not complete the treatment for various reasons, all the other 22 patients became symptoms free (no breathlessness) aft er treatment with inhalation of the smoke. Th ey could do their normal routine activities without breathlessness and did not need any further treatment with LABA, LAMA or ICS. Followed up for 6 months to 2 years and no relapse. In this presentation I will discuss about the anti-infl ammatory property of the smoke or tar of the burning Artimesia argyi and the possibility of developing a new anti-infl ammatory drug from isolating the active ingredients from the smoke or tar of burning Artimesia argyi.

Biography :

Qian Zeng was graduated from The Second Beijing Medical College in China in 1983. He has migrated to Australia in 1985, qualifi ed the examination for overseas doctors in Australia in 1997 and worked as a Resident in Alfred Hospital and Monash Medical Centre from 1997 to 2000. He has made self-research on antiinfl ammatory therapy for chronic infl ammatory diseases from 2001 to 2011 and he is also working as a General Practitioner at Medi7 Clinic Bentleigh, Melbourne and continuing research on anti-infl ammatory therapy from 2012 to till date. His main interest is to combine Modern Western Medicine with Traditional Chinese Medicine to develop a new anti-infl ammatory therapy for treating chronic infl ammatory diseases.

Email: qianzng@yahoo.com.au